Alnylam Pharmaceuticals Inc (NAS:ALNY)
$ 266.25 -2.7 (-1%) Market Cap: 34.34 Bil Enterprise Value: 33.21 Bil PE Ratio: 0 PB Ratio: 1,065.00 GF Score: 78/100

Alnylam Pharmaceuticals Inc Annual Shareholders Meeting Transcript

May 06, 2020 / 04:00PM GMT
Release Date Price: $145.27 (+2.86%)
Michael W. Bonney
Alnylam Pharmaceuticals, Inc. - Independent Chairman

Good morning or good afternoon depending upon your time zone, and thank you for your participation today. At the outset, we would like to express our immense gratitude to the health care professionals, other first responders and those who support them, who are leading the charge to combat COVID-19 pandemic. Your compassion, courage and commitment to us, your patients, in this time of need is inspiring. I would like to call to order the 2020 Annual Meeting of Stockholders of Alnylam Pharmaceuticals, Inc., which is being held virtually via the Internet. I am Mike Bonney, Chair of the Board of Directors of the company.

I'd like to introduce the other directors who are with us today for the annual meeting: Denny Ausiello; Olivier Brandicourt; Marsha Fanucci; Margaret Hamburg; John Maraganore, who is the company's Chief Executive Officer; Steve Paul, Colleen Reitan; Paul Schimmel; Amy Schulman; and Phil Sharp, constituting a majority of the members of our Board. I'd also like to take this opportunity to publicly thank Dr. Paul

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot